Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:CIPLAHealthcare
Clear all filters
NEWS
positive
Business Standard - Markets 12d ago

Cipla Ltd soars 2.53%, up for fifth straight session

Cipla Ltd is quoting at Rs 1476.6, up 2.53% on the day as on 12:44 IST on the NSE. The stock is down 1.95% in last one year as compared to a 6.16% drop in NIFTY and a 14.71% drop in the Nifty Pharma.

AONELIQUIDAONENIFTYAONETMMQ50AONETOTALCIPLAPHARMABEESFinancial ServicesHealthcare
Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%
positive
Business Standard - Markets 12d ago

Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%

In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.

AJANTPHARMAONETMMQ50AONETOTALBANKIETFCIPLAMOCAPITALPHARMABEESPVTBANIETFFinancial ServicesHealthcare
F&O strategy: Analyst recommends Bull Spread on Cipla, United Spirits
positive
Business Standard - Markets 12d ago

F&O strategy: Analyst recommends Bull Spread on Cipla, United Spirits

Here's why Nandish Shah technical research analyst of HDFC Securities recommends a 'Bull Spread' strategy on Cipla and United Spirits derivatives for the July series.

CIPLASHAHUNITDSPRCapital GoodsFast Moving Consumer Goods
Indian pharma firms gear up to supply key cancer drug to US
negative
ET Markets - Industry 18d ago

Indian pharma firms gear up to supply key cancer drug to US

Indian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading companies like Zydus, Cipla, Alkem, and Aurobindo Pharma are in discussions to supply the medicine. The US FDA has reached out to Indian pharmaceutical bodies, seeking manufacturers capable of producing the drug in various strengths to ensure availability for cancer patients.

ALKEMAUROPHARMACIPLAVITALChemicalsHealthcare
Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox
neutral
Google News - India Markets 18d ago

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply - Upstox

Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supplyUpstox

ALKEMCIPLAHealthcare
Cipla Share Price Live Updates: Cipla's Stock Price Movement
positive
ET Markets - Stocks 18d ago

Cipla Share Price Live Updates: Cipla's Stock Price Movement

ARSSBLCIPLAFinancial ServicesHealthcare
Market trading guide: Cipla among 2 stock recommendations for Tuesday - The Economic Times
neutral
Google News - India Markets 19d ago

Market trading guide: Cipla among 2 stock recommendations for Tuesday - The Economic Times

Market trading guide: Cipla among 2 stock recommendations for TuesdayThe Economic Times

CIPLAHealthcare
Market trading guide: Cipla among 2 stock recommendations for Tuesday
positive
ET Markets - Stocks 19d ago

Market trading guide: Cipla among 2 stock recommendations for Tuesday

Cipla and Knowledge Marine feature among analysts' top stock picks for Tuesday, backed by bullish technical breakouts, improving momentum indicators and strong chart structures that signal further upside potential.

AONETMMQ50CIPLAKMEWMARINEMOMENTUMCapital GoodsFinancial Services
Top gainers and losers, June 22: Cipla jumps 5%, Tech Mahindra, Dr. Reddy’s up 2%, Titan down 1%; check list - Upstox
negative
Google News - India Markets 19d ago

Top gainers and losers, June 22: Cipla jumps 5%, Tech Mahindra, Dr. Reddy’s up 2%, Titan down 1%; check list - Upstox

Top gainers and losers, June 22: Cipla jumps 5%, Tech Mahindra, Dr. Reddy’s up 2%, Titan down 1%; check listUpstox

CIPLAM&MTECHTECHMTITANZTECHAutomobile and Auto ComponentsConsumer Durables